NPY family of hormones: clinical relevance and potential use in gastrointestinal disease.

Abstract:

:The neuropeptide Y (NPY), peptide YY (PYY) and pancreatic polypeptide (PP) family of hormones exhibit a wide variety of biological actions on the mammalian gastrointestinal tract through known G-protein coupled receptor pathways. At least four receptor subtypes, denoted as Y(1), Y(2), Y(4) an Y(5), each with specific affinities to NPY ligands, serve as regulators of mucosal function, gastrointestinal motility and secretion. Investigations to date, however, have implicated the NPY peptides as mediators in the pathogenesis of numerous gastrointestinal disorders, including malabsorption, short gut, inflammatory bowel diseases, and forms of pancreatitis. Our understanding of these diseases and the interactions of NPY peptides have been advanced by the development of receptor agonists and antagonists that can be used experimentally in animal models. Potent selective PYY agonists have been developed that exhibit clinical potential as proabsorptive agents. NPY receptor agonists and antagonists as well as mice harboring null mutations in the Y(1) and Y(4) receptors have provided novel approaches in preventing intestinal inflammation and diarrhea. The use of competitive antagonists and Y(2) receptor knockouts have also aided in understanding secretory tone and electrogenic ion transport in the colon. In the pancreas, PYY suppresses amylase and cytokine release, which would be desirable in the clinical therapy of pancreatitis. Protein/DNA array analysis has revealed that PYY reduces transcription factor binding activity and disrupts signal transduction pathways activated by TNF-alpha in acinar cells. The present review gives an overview of NPY research in gastrointestinal disease and discusses its clinical relevance and potential use as therapy.

journal_name

Curr Top Med Chem

authors

Vona-Davis LC,McFadden DW

doi

10.2174/156802607782340966

subject

Has Abstract

pub_date

2007-01-01 00:00:00

pages

1710-20

issue

17

eissn

1568-0266

issn

1873-4294

journal_volume

7

pub_type

杂志文章,评审
  • The Role of Purinergic Signaling in Trichomonas vaginalis Infection.

    abstract::Trichomoniasis, one of the most common non-viral sexually transmitted infections worldwide, is caused by the parasite Trichomonas vaginalis. The pathogen colonizes the human urogenital tract, and the infection is associated with complications such as adverse pregnancy outcomes, cervical cancer, and an increase in HIV ...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/1568026620999200904122212

    authors: Ferla M,Tasca T

    更新日期:2021-01-01 00:00:00

  • PPAR ligands for metabolic disorders.

    abstract::As master regulators of lipid metabolism the peroxisome proliferator activated receptor (PPAR) family controls a wide variety of cellular processes, and thus it is not surprising that a large effort has focussed on discovering agents to pharmacologically modulate activity of these receptors. Early generation PPAR liga...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026033451673

    authors: Etgen GJ,Mantlo N

    更新日期:2003-01-01 00:00:00

  • Ethnobotany and natural products: the search for new molecules, new treatments of old diseases or a better understanding of indigenous cultures?

    abstract::Results of various projects on Mexican Indian ethnobotany and some of the subsequent pharmacological and phytochemical studies are summarised focusing both on chemical-pharmacological as well as anthropological (ethnopharmacological) aspects of our research. We have identified taste and smell properties of medicinal (...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026033392570

    authors: Heinrich M

    更新日期:2003-01-01 00:00:00

  • Glutamate receptor agonists: stereochemical aspects.

    abstract::The neurotransmitter (S)-glutamate [(S)-Glu] is responsible for most of the excitatory neurotransmission in the central nervous system. The effect of (S)-Glu is mediated by both ionotropic and metabotropic receptors. Glutamate receptor agonists are generally α-amino acids with one or more stereogenic centers due to st...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/156802611795164990

    authors: Vogensen SB,Greenwood JR,Bunch L,Clausen RP

    更新日期:2011-01-01 00:00:00

  • Medicinal chemistry of aptamers.

    abstract::Aptamers- short nucleic acid or peptide ligands- attracted considerable attention across various disciplines as target specific therapeutic, delivery vehicle and diagnostic tools. The applicability of aptamers - often termed as 'chemical antibodies' - continues to grow and possess certain edge over the antibody counte...

    journal_title:Current topics in medicinal chemistry

    pub_type: 社论

    doi:10.2174/1568026615666150413161707

    authors: Veedu RN

    更新日期:2015-01-01 00:00:00

  • Current Breakthroughs in Structure-based Design of Synthetic and Natural Sourced Inhibitors Against Zika Viral Targets.

    abstract:BACKGROUND:Zika is a worldwide pandemic dreadful viral transmission through Aedes mosquito vector. It significantly causes fever, joint pain or rash, and conjunctivitis. Pregnant mothers suffering from Zika viral infection may have fetal abnormalities due to severe neurological problems, characterized by microcephaly a...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/1568026619666181120125525

    authors: Nandi S,Kaur R,Kumar M,Sharma A,Naaz A,Mandal SC

    更新日期:2018-01-01 00:00:00

  • A2A receptor ligands: past, present and future trends.

    abstract::The adenosine A(2A) receptor is a member of the G protein-coupled receptor family and mediates multiple physiological effects of adenosine, both at the central nervous system and at peripheral tissues. Increasing evidence relates the A(2A) receptor with several pathological conditions such as neurodegenerative disorde...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/156802610791268765

    authors: Clementina M,Giuseppe S

    更新日期:2010-01-01 00:00:00

  • Insights into Aβ aggregation: a molecular dynamics perspective.

    abstract::This article reviews recent molecular dynamics simulations of the Alzheimer's amyloid-β protein, the primary component of the amyloid plaques found in the brain of Alzheimer's patients. Different simulation techniques, and their application to the study of monomeric, oligomeric, and fibrillar species is discussed. Thi...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026611212220012

    authors: Shea JE,Urbanc B

    更新日期:2012-01-01 00:00:00

  • Current Advances and Limitations of Deep Learning in Anticancer Drug Sensitivity Prediction.

    abstract::Anticancer drug screening can accelerate drug discovery to save the lives of cancer patients, but cancer heterogeneity makes this screening challenging. The prediction of anticancer drug sensitivity is useful for anticancer drug development and the identification of biomarkers of drug sensitivity. Deep learning, as a ...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/1568026620666200710101307

    authors: Tan X,Yu Y,Duan K,Zhang J,Sun P,Sun H

    更新日期:2020-01-01 00:00:00

  • Ring closing metathesis in the synthesis of biologically interesting peptidomimetics, sugars and alkaloids.

    abstract::Olefin metathesis has rapidly established itself as an essential tool in the synthetic chemist's armoury. The ease of operation and functional group tolerance that is obtained with the modern generation of catalysts makes the use of metathesis an extremely attractive option when preparing medicinally interesting molec...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/156802605775009757

    authors: Martin WH,Blechert S

    更新日期:2005-01-01 00:00:00

  • The Importance of Bioactivation in Computer-Guided Drug Repositioning. Why the Parent Drug is Not Always Enough.

    abstract::Although bioactivation is a well-documented process and the role of active metabolites in the drug discovery field has long been recognized, drug metabolites are usually ignored in virtual screening campaigns oriented to drug repositioning. The present article discusses different issues related to overlooking of the a...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026616666160216155043

    authors: Talevi A

    更新日期:2016-01-01 00:00:00

  • Aminoquinoline melanin-concentrating hormone 1-receptor (MCH1-R) antagonists.

    abstract::Structure-activity relationships of a 4-aminoquinoline MCH-1R antagonist lead series were explored by synthesis of analogs with modifications at the 2-, 4- and 6-positions of the original HTS hit. Improvements to the original screening lead were made by addition of lipophilic groups at the 2-position and biphenyl, cyc...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/156802607782194789

    authors: DeVita RJ

    更新日期:2007-01-01 00:00:00

  • Chemistry and Biology of Farnesol and its Derivatives: Quorum Sensing Molecules with Immense Therapeutic Potential.

    abstract:BACKGROUND:Farnesol is an acyclic sesquiterpene alcohol, endogenously synthesized via the ergosterol pathway. It is a quorum sensing molecule (QSM) that was first discovered in C. albicans, and is involved in the inhibition of hyphae formation. METHODS:This review focuses on the comprehensive details of occurrence, ch...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026619666181210124159

    authors: Gupta P,Sharma M,Arora N,Pruthi V,Poluri KM

    更新日期:2018-01-01 00:00:00

  • Target-related affinity profiling: Telik's lead discovery technology.

    abstract::Target-Related Affinity Profiling (TRAP) is a computational drug discovery technology that is based on 'affinity fingerprints', which are molecular descriptors derived from the protein binding preferences of small molecules. The underlying concepts of TRAP are reviewed. Affinity fingerprints are compared to molecular ...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026053828394

    authors: Beroza P,Damodaran K,Lum RT

    更新日期:2005-01-01 00:00:00

  • G Protein Coupled Receptors And Structure-Based Advances.

    abstract::G protein coupled receptors (GPCRs) are membrane proteins coupled with G proteins through which they transmit signals to the cytoplasm. Approximately 30% of pharmaceuticals target these receptors, even though crystal structures were scarce at the time. Furthermore, an additional 15% of GPCRs have yet to be exploited f...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026615666150915121324

    authors: Kontoyianni M

    更新日期:2016-01-01 00:00:00

  • 1,2,4-Triazole: A Privileged Scaffold for the Development of Potent Antifungal Agents - A Brief Review.

    abstract::Over the past decades, a tremendous rise in invasive fungal infection diseases attributed to the yeast Candida albicans in immunocompromised individuals poses a seriously challenging issue. Another concern is the emergence of multi-drug resistant pathogens to the existing medicines due to their overuse and misuse. It ...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/1568026620666200704140107

    authors: Tratrat C

    更新日期:2020-01-01 00:00:00

  • TSAO compounds: the comprehensive story of a unique family of HIV-1 specific inhibitors of reverse transcriptase.

    abstract::Emergence of drug-resistant viral strains is one of the major milestones and the main cause for the failure of antiretroviral therapy. Combination of different anti-HIV agents has become the standard clinical practice to keep the viral load at low or even undetectable levels and to prevent emergence of virus-drug resi...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026043388600

    authors: Camarasa MJ,San-Félix A,Velázquez S,Pérez-Pérez MJ,Gago F,Balzarini J

    更新日期:2004-01-01 00:00:00

  • Rational understanding of nicotinic receptors drug binding.

    abstract::The atomic determination of the acetylcholine binding protein (AChBP), a molluscan cholinergic protein, homologous to the amino-terminal extracellular domain of nicotinic receptors (nAChRs), offers opportunities for the modeling of the acetylcholine binding site and its ligands. Recently, we constructed three-dimensio...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026043451177

    authors: Grutter T,Le Novère N,Changeux JP

    更新日期:2004-01-01 00:00:00

  • New therapeutic frontiers for metabotropic glutamate receptors.

    abstract::Our understanding of glutamatergic transmission in the central nervous system has been greatly expanded with the discovery and investigation of the metabotropic glutamate receptor family. Complementing the ionotropic glutamate-gated ion channels, these G-protein coupled receptors play critical roles in neuronal and gl...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026054750254

    authors: Niswender CM,Jones CK,Conn PJ

    更新日期:2005-01-01 00:00:00

  • Half a century of L-DOPA.

    abstract::L-DOPA is a di-hydroxy-phenyl, catecholamine precursor, amino acid, initially considered as an inert compound and now the key stone for the treatment of Parkinson's disease (PD) and some hereditary dystonias. L-DOPA, when administered to mammals, is rapidly metabolized to dopamine and 3-OM-DOPA, and its half-life in p...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:

    authors: Mena MA,Casarejos MJ,Solano RM,de Yébenes JG

    更新日期:2009-01-01 00:00:00

  • The IC(50) concept revisited.

    abstract::A major strategy used in drug design is the inhibition of enzyme activity. The ability to accurately measure the concentration of the inhibitor which is required to inhibit a given biological or biochemical function by half is extremely important in ranking compounds. Since the concept of the half maximal inhibitory c...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/156802612800672844

    authors: Caldwell GW,Yan Z,Lang W,Masucci JA

    更新日期:2012-01-01 00:00:00

  • Achievements in Cancer Research and its Therapeutics in Hundred Years.

    abstract::Cancer research has progressed leaps and bounds over the years. This review is a brief overview of the cancer research, milestone achievements and therapeutic studies on it over the one hundred ten years which would give us an insight into how far we have come to understand and combat this fatal disease leading to mil...

    journal_title:Current topics in medicinal chemistry

    pub_type: 历史文章,杂志文章,评审

    doi:10.2174/1568026619666190730093034

    authors: Shastri S,Chatterjee B,Thakur SS

    更新日期:2019-01-01 00:00:00

  • PET radioligands for the vesicular acetylcholine transporter (VAChT).

    abstract::The vesicular acetylcholine transporter (VAChT) is a glycoprotein responsible for the accumulation of acetylcholine into pre-synaptic vesicules of cholinergic neurons. Cholinergic innervation has been shown to be decreased at the earlier stages of Alzheimer's disease (AD). Thus, the expression of VAChT has been correl...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/156802610793176846

    authors: Giboureau N,Som IM,Boucher-Arnold A,Guilloteau D,Kassiou M

    更新日期:2010-01-01 00:00:00

  • Electrochemically driven supramolecular interaction of quinones and ferrocifens: an example of redox activation of bioactive compounds.

    abstract::This review discusses the state of the art, challenges and perspectives in recent applications of electrochemistry in the life sciences. It deals mainly with the elucidation of molecular mechanisms of drug action, drug design and development, involving electron transfer, pharmaco-electrochemistry (the combination of e...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:

    authors: de Paiva YG,da Rocha Ferreira F,Silva TL,Labbe E,Buriez O,Amatore C,Fonseca Goulart MO

    更新日期:2015-01-01 00:00:00

  • Iron chelators in cancer chemotherapy.

    abstract::Iron chelators may be of value as therapeutic agents in the treatment of cancer. They may act by depleting iron, a necessary nutrient, and limiting tumor growth. Alternatively or additionally, they may form redox-active metal complexes that cause oxidative stress via production of reactive oxygen species, damaging cri...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026043387269

    authors: Buss JL,Greene BT,Turner J,Torti FM,Torti SV

    更新日期:2004-01-01 00:00:00

  • Recent Trends in Drug Design and Discovery.

    abstract:INTRODUCTION:Structure-based drug design is a wide area of identification of selective inhibitors of a target of interest. From the time of the availability of three dimensional structure of the drug targets, mostly the proteins, many computational methods had emerged to address the challenges associated with drug desi...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/1568026620666200622150003

    authors: Velmurugan D,Pachaiappan R,Ramakrishnan C

    更新日期:2020-01-01 00:00:00

  • Antiproliferative Activity of 8-methoxy Ciprofloxacin-Hydrozone/Acylhydrazone Scaffolds.

    abstract:AIMS:A series of 8-methoxy ciprofloxacin- hydrazone/acylhydrazone hybrids were evaluated for their activity against a panel of cancer cell lines including HepG2 liver cancer cells, MCF-7, doxorubicin- resistant MCF-7 (MCF-7/DOX) breast cancer cells, DU-145 and multidrug-resistant DU145 (MDR DU-145) prostate cancer cell...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/1568026620666200603105644

    authors: Wang LP,Xu Z,Deng GY,Xu SL

    更新日期:2020-01-01 00:00:00

  • Proteases in Mosquito Borne Diseases: New Avenues in Drug Development.

    abstract:INTRODUCTION:Mosquito borne diseases continue to propagate and cause millions of deaths annually. They are caused either by protozoan parasites such as Plasmodium, Toxoplasma or by flaviviruses including Dengue and Zika. Among the proteome of such parasitic organisms, proteases play essential roles in events such as ho...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026617666170130122231

    authors: Pant A,Pasupureddy R,Pande V,Seshadri S,Dixit R,Pandey KC

    更新日期:2017-01-01 00:00:00

  • New Drugs and Therapeutic/Diagnostic Targets for Fungal and Parasitic Diseases - Part I.

    abstract:: ...

    journal_title:Current topics in medicinal chemistry

    pub_type: 社论

    doi:10.2174/156802661815181101110430

    authors: Dea-Ayuela MA,Serrano DR

    更新日期:2018-01-01 00:00:00

  • L-Histidinol Dehydrogenase as a New Target for Old Diseases.

    abstract::Bacterial infections constitute an always growing health problem worldwide. The resistance to antibiotics of an increasing number of bacterial pathogens necessitates a permanent search for new molecules with different mechanisms of action. Histidine biosynthesis is an ancient pathway found in bacteria, archaebacteria,...

    journal_title:Current topics in medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/1568026616666160413140000

    authors: Monti SM,De Simone G,D'Ambrosio K

    更新日期:2016-01-01 00:00:00